BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25355465)

  • 1. Long-term health-related quality of life after curative treatment for prostate cancer: a regional cross-sectional comparison of two standard treatment modalities.
    Hjälm-Eriksson M; Lennernäs B; Ullén A; Johansson H; Hugosson J; Nilsson S; Brandberg Y
    Int J Oncol; 2015 Jan; 46(1):381-8. PubMed ID: 25355465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.
    Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
    Wahlgren T; Brandberg Y; Häggarth L; Hellström M; Nilsson S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):51-9. PubMed ID: 15337539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
    Wahlgren T; Nilsson S; Lennernäs B; Brandberg Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):662-70. PubMed ID: 17499452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
    Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
    Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
    Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
    BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
    Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
    BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation.
    Hjälm-Eriksson M; Ullén A; Nilsson S; Johansson H; Nilsson J; Castellanos E; Brandberg Y
    Acta Oncol; 2022 Oct; 61(10):1179-1185. PubMed ID: 36062835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer.
    Galalae RM; Loch T; Riemer B; Rzehak P; Küchler T; Kimmig B; Kovács G
    Strahlenther Onkol; 2004 Sep; 180(9):582-9. PubMed ID: 15378189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
    Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
    Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
    Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.
    Park J; Shin DW; Yun SJ; Park SW; Jeon SS; Kwak C; Kwon TG; Kim HJ; Ahn H
    Oncology; 2013; 85(5):299-305. PubMed ID: 24217330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of high dose rate brachytherapy in combination with external beam radiotherapy on men's health-related quality of life and sexual function over a 2 year time span.
    Conaglen HM; de Jong D; Hartopeanu C; Conaglen JV; Tyrie LK
    Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):197-204. PubMed ID: 23183305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-specific quality of life among patients with localized prostate cancer: an Australian perspective.
    Newton FJ; Burney S; Millar JL; Frydenberg M; Ng KT
    BJU Int; 2006 Jun; 97(6):1179-83. PubMed ID: 16686708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients.
    Putora PM; Engeler D; Haile SR; Graf N; Buchauer K; Schmid HP; Plasswilm L
    Strahlenther Onkol; 2016 Mar; 192(3):182-9. PubMed ID: 26713323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost: a cross-sectional quality-of-life survey.
    Vordermark D; Wulf J; Markert K; Baier K; Kölbl O; Beckmann G; Bratengeier K; Noe M; Schön G; Flentje M
    Acta Oncol; 2006; 45(6):708-16. PubMed ID: 16938814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes.
    Lennernäs B; Majumder K; Damber JE; Albertsson P; Holmberg E; Brandberg Y; Isacsson U; Ljung G; Damm O; Nilsson S
    Acta Oncol; 2015 Jun; 54(6):875-81. PubMed ID: 25362844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less satisfaction with information in patients with prostate cancer treated with surgery and salvage radiotherapy compared with patients treated with curative radiotherapy alone, despite similar health-related quality of life.
    Majumder K; Brandberg Y; Johansson H; Nilsson S; Bergenmar M
    Clin Genitourin Cancer; 2014 Jun; 12(3):e71-82. PubMed ID: 24445250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.